Navigation Links
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
Date:4/29/2009

IP protection to our NeuroTrans(TM) program. The broad claims are designed to protect the use of our NeuroTrans(TM) CNS targeting peptides and the extensive range of potential uses of NeuroTrans(TM) in treating CNS disorders. We believe the intellectual property protections established by these patent allowances will significantly enhance our ability to form strong development collaborations with potential partners to advance NeuroTrans(TM) into clinical trials in neurodegenerative diseases."

About NeuroTrans(TM)

NeuroTrans(TM) is Raptor's proprietary receptor-associated protein ("RAP")-based technology program designed to deliver therapeutics across the blood-brain barrier ("BBB"), with the potential to provide safer, less intrusive, and more effective therapies to treat a wide variety of brain disorders. Preclinical studies indicate that radio-labeled NeuroTrans(TM) crosses the BBB through transcytosis, or the selective receptor-mediated transport of peptides and large proteins across the endothelial membrane in the BBB. NeuroTrans(TM) has also been conjugated to a variety of protein drugs, including enzymes and growth factors, without interfering with their therapeutic functions.

About Raptor Pharmaceuticals Corp.

Raptor Pharmaceuticals Corp. ("Raptor") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. Raptor focuses on underserved patient populations where it believes it can have the greatest potential impact. Raptor currently has product candidates in clinical development to treat nephropathic cystinosis, non-alcoholic steatohepatitis ("NASH"), Huntington's Disease ("Huntington's"), and aldehyde dehydrogenase ("ALDH2") deficiency.

Raptor's preclinical programs are based upon bioengineered novel dr
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Provides Update of Product Programs
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... TWi Pharmaceuticals, Inc. (4180.TT) today announced that ... States Food and Drug Administration (FDA) on its ... 125mg/ml oral suspension, the generic equivalent to Par ... under Hatch Waxman rules, it will be entitled ... completed the pre-launch preparation of the generic drug.  ...
(Date:8/27/2014)... Columbia and MENLO PARK, Calif. ... Inc. , (OTCQB: DMPI), developer of advanced cancer ... at the 16th Annual Rodman & Renshaw Global Investment ... LLC. The presentation will take place Tuesday, September 9th at ... floor) at the New York Palace Hotel in ...
(Date:8/27/2014)... 27, 2014 Varian Medical Systems (NYSE: VAR) today broke ... Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full ... " Utah is home ... of whom can be credited with Varian,s success in the ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4
... Nfocus Neuromedical, Inc., an innovative medical device company ... brain aneurysms, today announced that the company received U.S. ... Vessel Occlusion System (VOS).  The Acta VOS provides physicians ... an array of common and potentially serious vascular lesions. ...
... 11, 2011 Reportlinker.com announces that a new ... Novo Nordisk A/S: PharmaVitae Profile ... Introduction This analysis ... Nordisk in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
(Date:8/27/2014)... For those who want to build ... products are very practical. Top10BestSEOHosting.com today announces that ... the best ASP.NET hosting suppliers of this year. ... top web hosting provider for a long time, ... today. Recently proclaimed one of the fastest growing ...
(Date:8/27/2014)... Arrow, OK (PRWEB) August 27, 2014 When ... their guests a comfortable bed to sleep without breaking the ... the market for a new foam mattress set for the ... to sleep on, Bedding Mart has it all during their ... stock up on some of the best mattresses for the ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 Taking ... extremes, the Steele Creek YMCA will host its ... Race on Saturday, September 13 at YMCA Camp ... in three race divisions: adult, youth and teams. Within ... pushing themselves to their physical limit - for a worthy ...
(Date:8/27/2014)... Canada Goose Parkas from CanadaGooseJackor.nu are great. By ... With unique detailing such as buttons, leather trim and a ... in opulence. Recently, the company has unveiled its new range ... , True enough, the new assortment comes in various popular ... off) on all these brand new items. By launching the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The New ... ) is holding free events about “ Sexuality & ... Liz Treston. These straightforward and entertaining discussions are for ... Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) and October ... Avenue, Bethpage, NY). , The New York Mobility ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2
... fiber is perhaps the first thing that doctors and ... a condition characterized by enlargement of blood vessels, in ... bleeding and uneasiness. ,According to the American Society ... by a variety of factors, including pregnancy, chronic constipation ...
... U.S President Bill Clinton is on a different trip. Bill Clinton ... grew up on rich, fat laden diets that did not even ... serious health trouble, leading to a major bypass surgery. Now, with ... with a motive to make the future generation, a leaner lot! ...
... blue Smarties will no longer fascinate kids after maker ... from them//. Nestlé said that it was only reacting ... that the artificial color could harm children. ... coloring was the one, which was most likely to ...
... billion for providing a nutritious diet to undernourished women ... the previous year. ,The main beneficiary would ... who will get the supplementary nutritious diet from mother ... and child welfare department official. ,The state's ...
... diet not only makes you slim, it may help ... Leeuwenburgh and other scientists from the University of Florida's ... calories a day and moderately increased the animals' activity. ... their average and significantly overturned the negative effects of ...
... have near normal lung function and seem to perform ... cancer patients//. Similarly, male lung cancer patients were likely ... which is characterized by progressive deterioration in lung function. ... the CHEST journal, a publication of the American College ...
Cached Medicine News:Health News:Male Lung Cancer Patients Less Likely To Perform Well in Lung Function Tests 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: